このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Medpace Holdings マネジメント
マネジメント 基準チェック /44
Medpace Holdings'の CEO はAugust Troendleで、 Jul1992年に任命され、 の在任期間は 32.08年です。 の年間総報酬は$ 1.65Mで、 49.5%給与と50.5%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の17.42%を直接所有しており、その価値は$ 2.10B 。経営陣と取締役会の平均在任期間はそれぞれ5.5年と6年です。
主要情報
August Troendle
最高経営責任者
US$1.6m
報酬総額
| CEO給与比率 | 49.5% |
| CEO在任期間 | 32.2yrs |
| CEOの所有権 | 17.4% |
| 経営陣の平均在職期間 | 5.6yrs |
| 取締役会の平均在任期間 | 6.1yrs |
経営陣の近況
Recent updates
Medpace Holdings, Inc.'s (NASDAQ:MEDP) Earnings Haven't Escaped The Attention Of Investors
Sep 19
Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Sep 02Medpace: Continued Business Growth With Asymmetrical Payoff Opportunity
Aug 20Why Medpace Holdings' (NASDAQ:MEDP) Earnings Are Better Than They Seem
Jul 31Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jul 25What You Can Learn From Medpace Holdings, Inc.'s (NASDAQ:MEDP) P/E
Jun 18Medpace: Clear Winner If China Blockade Succeeds
Jun 04A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
May 22Does Medpace Holdings (NASDAQ:MEDP) Deserve A Spot On Your Watchlist?
Apr 12Medpace: Exceptional Performance, Almost Fully Priced In
Mar 11Medpace Holdings, Inc.'s (NASDAQ:MEDP) 32% Jump Shows Its Popularity With Investors
Feb 18Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Feb 09A Look At The Intrinsic Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jan 25Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Jan 10Shareholders Should Be Pleased With Medpace Holdings, Inc.'s (NASDAQ:MEDP) Price
Dec 26Should You Investigate Medpace Holdings, Inc. (NASDAQ:MEDP) At US$275?
Nov 08Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 29% Below Their Intrinsic Value Estimate
Oct 23If EPS Growth Is Important To You, Medpace Holdings (NASDAQ:MEDP) Presents An Opportunity
Oct 10Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Aug 27Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Jul 31A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jul 18Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Jul 04Is Medpace Holdings (NASDAQ:MEDP) A Risky Investment?
May 25Is Now The Time To Look At Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?
Apr 27An Intrinsic Calculation For Medpace Holdings, Inc. (NASDAQ:MEDP) Suggests It's 28% Undervalued
Apr 12We Ran A Stock Scan For Earnings Growth And Medpace Holdings (NASDAQ:MEDP) Passed With Ease
Mar 27Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Feb 14What Is Medpace Holdings, Inc.'s (NASDAQ:MEDP) Share Price Doing?
Jan 16Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jan 03Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Dec 20Medpace Holdings (NASDAQ:MEDP) Has A Rock Solid Balance Sheet
Nov 16Growth Investors: Industry Analysts Just Upgraded Their Medpace Holdings, Inc. (NASDAQ:MEDP) Revenue Forecasts By 13%
Nov 03CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$340m |
| Mar 31 2024 | n/a | n/a | US$312m |
| Dec 31 2023 | US$2m | US$814k | US$283m |
| Sep 30 2023 | n/a | n/a | US$273m |
| Jun 30 2023 | n/a | n/a | US$268m |
| Mar 31 2023 | n/a | n/a | US$257m |
| Dec 31 2022 | US$2m | US$770k | US$245m |
| Sep 30 2022 | n/a | n/a | US$227m |
| Jun 30 2022 | n/a | n/a | US$209m |
| Mar 31 2022 | n/a | n/a | US$199m |
| Dec 31 2021 | US$6m | US$697k | US$181m |
| Sep 30 2021 | n/a | n/a | US$182m |
| Jun 30 2021 | n/a | n/a | US$175m |
| Mar 31 2021 | n/a | n/a | US$159m |
| Dec 31 2020 | US$4m | US$608k | US$145m |
| Sep 30 2020 | n/a | n/a | US$124m |
| Jun 30 2020 | n/a | n/a | US$107m |
| Mar 31 2020 | n/a | n/a | US$110m |
| Dec 31 2019 | US$8m | US$504k | US$100m |
| Sep 30 2019 | n/a | n/a | US$93m |
| Jun 30 2019 | n/a | n/a | US$88m |
| Mar 31 2019 | n/a | n/a | US$78m |
| Dec 31 2018 | US$528k | US$420k | US$73m |
| Sep 30 2018 | n/a | n/a | US$61m |
| Jun 30 2018 | n/a | n/a | US$52m |
| Mar 31 2018 | n/a | n/a | US$45m |
| Dec 31 2017 | US$598k | US$419k | US$39m |
報酬と市場: Augustの 総報酬 ($USD 1.65M ) は、 US市場 ($USD 13.17M ) の同様の規模の企業の平均を下回っています。
報酬と収益: Augustの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
August Troendle (68 yo)
32.2yrs
在職期間
US$1,646,031
報酬
Dr. August James Troendle, M.D. serves as Chairman of CinRx Pharma, LLC. He has been the Chairman, Chief Executive Officer at Medpace Holdings, Inc. since July 1992 and served as its President since July 1...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman & CEO | 32.2yrs | US$1.65m | 17.42% $ 1.8b | |
| President | 3.1yrs | US$945.08k | 0.070% $ 7.0m | |
| CFO & Treasurer | 5.6yrs | US$690.48k | 0.019% $ 2.0m | |
| Executive Vice President of Operations | 7.7yrs | US$1.12m | 0.19% $ 18.8m | |
| Chief Compliance Officer | 12.3yrs | US$914.64k | 0.043% $ 4.4m | |
| Chief Information Officer | 3.7yrs | データなし | データなし | |
| Associate Director of Investors Relations | no data | データなし | データなし | |
| Vice President of Business Development & Marketing | no data | データなし | データなし | |
| Senior Vice President of Commercial Operations & Clinical Pharmacology Unit | no data | データなし | データなし | |
| Chief Medical Officer of Medical Department | 1.7yrs | データなし | データなし | |
| Senior Vice President of Clinical Monitoring | no data | データなし | データなし |
5.6yrs
平均在職期間
58yo
平均年齢
経験豊富な経営陣: MEDPの経営陣は経験豊富で経験豊富です（平均在職期間は5.5年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman & CEO | 32.2yrs | US$1.65m | 17.42% $ 1.8b | |
| Lead Independent Director | 6.1yrs | US$264.98k | 0.0065% $ 652.9k | |
| Independent Director | 6.1yrs | US$217.48k | 0.017% $ 1.7m | |
| Independent Director | 8.2yrs | US$227.35k | 0.0017% $ 169.5k | |
| Independent Director | 8.2yrs | US$234.97k | 0.070% $ 7.1m | |
| Independent Director | 1.7yrs | US$258.37k | 0% $ 0 | |
| Director | less than a year | データなし | データなし |
6.1yrs
平均在職期間
66yo
平均年齢
経験豊富なボード: MEDPの 取締役会 は 経験豊富 であると考えられます ( 6年の平均在任期間)。